Electrocore LLC (ECOR)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $48.44M
Last updated: Nov 17, 2026 at 11:02 AM ET
Electrocore LLC (ECOR) Earnings: Report Dates and Results
Electrocore LLC (ECOR) is expected to report earnings on Mar 17, 2027. In the quarter ended Sep 30, 2026, Electrocore LLC reported EPS of -$0.13, above the -$0.26 estimate. It beat the EPS estimate in 4 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
ECOR has an expected report date of Mar 17, 2027.
ECOR Earnings Call
The latest ECOR earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 34 quarters below that had an estimate, ECOR beat 17, missed 15 and matched 2. Revenue for the quarter ended Sep 30, 2026 was $9.69M, up 11.5% from $8.69M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.13 | -$0.26 | -$0.31 - -$0.23 | +50.00% | Beat | N/A | 5 | 3 up, 1 down | Nov 4, 2026 | $9.69M |
| Jun 30, 2026 | -$0.33 | -$0.41 | -$0.50 - -$0.31 | +19.51% | Beat | N/A | 5 | 0 up, 1 down | Aug 6, 2026 | $9.45M |
| Mar 31, 2026 | -$0.59 | -$0.61 | -$0.68 - -$0.52 | +3.28% | Beat | N/A | 4 | 0 up, 4 down | May 6, 2026 | $9.58M |
| Dec 31, 2025 | -$0.34 | -$0.39 | -$0.46 - -$0.30 | +13.38% | Beat | N/A | 4 | 1 up, 1 down | Mar 19, 2026 | $9.24M |
| Sep 30, 2025 | -$0.40 | -$0.36 | -$0.45 - -$0.35 | -11.11% | Miss | N/A | 5 | 0 up, 0 down | Nov 5, 2025 | $8.69M |
| Jun 30, 2025 | -$0.44 | -$0.32 | N/A | -37.50% | Miss | N/A | N/A | 0 up, 0 down | Aug 6, 2025 | $7.38M |
| Mar 31, 2025 | -$0.47 | -$0.45 | N/A | -4.44% | Miss | N/A | N/A | 0 up, 0 down | May 7, 2025 | $6.72M |
| Dec 31, 2024 | -$0.40 | -$0.34 | N/A | -17.65% | Miss | N/A | N/A | 0 up, 0 down | Mar 12, 2025 | $7.05M |
| Sep 30, 2024 | -$0.31 | -$0.33 | -$0.36 - -$0.30 | +6.06% | Beat | N/A | 3 | 0 up, 0 down | Nov 13, 2024 | $6.55M |
| Jun 30, 2024 | -$0.38 | -$0.43 | -$0.48 - -$0.37 | +11.63% | Beat | N/A | 4 | 0 up, 0 down | Aug 7, 2024 | $6.14M |
| Mar 31, 2024 | -$0.53 | -$0.59 | -$0.70 - -$0.54 | +10.17% | Beat | N/A | 4 | 0 up, 0 down | May 8, 2024 | $5.44M |
| Dec 31, 2023 | -$0.61 | -$0.61 | -$0.63 - -$0.57 | 0.00% | In line | N/A | 4 | 0 up, 0 down | Mar 13, 2024 | $5.19M |
| Sep 30, 2023 | -$0.68 | -$0.79 | -$0.84 - -$0.51 | +13.92% | Beat | N/A | 6 | 0 up, 0 down | Nov 8, 2023 | $4.51M |
| Jun 30, 2023 | -$1.02 | -$0.93 | -$1.11 - -$0.70 | -9.68% | Miss | N/A | 6 | 4 up, 1 down | Aug 9, 2023 | $3.55M |
| Mar 31, 2023 | -$1.17 | -$0.99 | -$1.19 - -$0.61 | -18.18% | Miss | N/A | 5 | 1 up, 0 down | May 3, 2023 | $2.78M |
| Dec 31, 2022 | -$1.22 | -$1.12 | -$1.20 - -$1.03 | -8.93% | Miss | N/A | 5 | 1 up, 0 down | Mar 8, 2023 | $2.56M |
| Sep 30, 2022 | -$1.20 | -$1.05 | -$1.35 - -$0.90 | -14.29% | Miss | N/A | 5 | 1 up, 0 down | Nov 3, 2022 | $1.98M |
| Jun 30, 2022 | -$1.20 | -$1.05 | -$1.20 - -$0.90 | -14.29% | Miss | N/A | 5 | 0 up, 0 down | Aug 4, 2022 | $2.16M |
| Mar 31, 2022 | -$1.17 | -$1.05 | -$1.35 - -$0.75 | -11.43% | Miss | N/A | 5 | 0 up, 0 down | May 5, 2022 | $1.90M |
| Dec 31, 2021 | -$1.05 | -$1.02 | -$1.05 - -$0.90 | -2.94% | Miss | N/A | 6 | 0 up, 0 down | Mar 10, 2022 | $1.49M |
| Sep 30, 2021 | -$0.90 | -$1.20 | -$1.50 - -$1.05 | +25.00% | Beat | N/A | 6 | N/A | Nov 4, 2021 | $1.49M |
| Jun 30, 2021 | -$1.19 | -$1.72 | -$1.80 - -$1.65 | +30.81% | Beat | N/A | 5 | N/A | Aug 5, 2021 | $1.27M |
| Mar 31, 2021 | -$1.65 | -$1.69 | -$1.80 - -$1.50 | +2.37% | Beat | N/A | 4 | N/A | May 6, 2021 | $1.20M |
| Dec 31, 2020 | -$2.10 | -$1.56 | -$1.80 - -$1.20 | -34.62% | Miss | N/A | 5 | N/A | Mar 11, 2021 | $928265 |
| Sep 30, 2020 | -$1.50 | -$1.87 | -$2.70 - -$1.50 | +19.79% | Beat | N/A | 6 | N/A | Nov 12, 2020 | $1.08M |
| Jun 30, 2020 | -$1.95 | -$2.95 | N/A | +33.90% | Beat | N/A | 3 | N/A | Aug 13, 2020 | $752955 |
| Mar 31, 2020 | -$4.05 | -$3.45 | -$3.75 - -$3.15 | -17.39% | Miss | N/A | 2 | N/A | May 14, 2020 | $733771 |
| Dec 31, 2019 | -$4.35 | -$4.35 | -$4.80 - -$3.30 | 0.00% | In line | N/A | 4 | N/A | Mar 23, 2020 | $674942 |
| Sep 30, 2019 | -$4.89 | -$7.50 | N/A | +34.80% | Beat | N/A | 4 | N/A | Nov 13, 2019 | $682993 |
| Jun 30, 2019 | -$5.75 | -$7.12 | -$7.35 - -$5.85 | +19.24% | Beat | N/A | 3 | N/A | Aug 13, 2019 | $622743 |
| Mar 31, 2019 | -$7.05 | -$6.45 | N/A | -9.30% | Miss | N/A | 3 | N/A | May 14, 2019 | $409601 |
| Dec 31, 2018 | -$7.95 | -$8.00 | -$9.60 - -$7.05 | +0.63% | Beat | -39850.0% | 3 | N/A | Mar 28, 2019 | $367568 |
| Sep 30, 2018 | -$6.75 | -$5.70 | -$8.85 - -$4.80 | -18.42% | Miss | N/A | 3 | N/A | Nov 13, 2018 | $150972 |
| Jun 30, 2018 | -$3.15 | -$3.75 | -$7.80 - -$3.75 | +16.00% | Beat | N/A | 2 | N/A | Aug 13, 2018 | $393226 |
| Mar 31, 2018 | -$0.38 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 25, 2018 | $81187 |
| Dec 31, 2017 | $0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2018 | $234730 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$1.65, after -$1.62 the year before. It was $0.02 for the year ended Dec 31, 2017, the oldest of the 9 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$1.65 | N/A |
| Dec 31, 2024 | -$1.62 | N/A |
| Dec 31, 2023 | -$3.48 | N/A |
| Dec 31, 2022 | -$4.79 | N/A |
| Dec 31, 2021 | -$4.79 | N/A |
| Dec 31, 2020 | -$9.60 | N/A |
| Dec 31, 2019 | -$22.04 | N/A |
| Dec 31, 2018 | -$18.23 | -91225.0% |
| Dec 31, 2017 | $0.02 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 8,300 words across 10 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 8,292 | 10 | |
| 2026Q1 | Mar 31, 2026 | 7,119 | 8 | |
| 2025Q4 | Dec 31, 2025 | 4,455 | 7 | |
| 2025Q3 | Sep 30, 2025 | 6,178 | 8 | |
| 2025Q2 | Jun 30, 2025 | 4,117 | 5 | |
| 2025Q1 | Mar 31, 2025 | 5,414 | 5 | |
| 2024Q4 | Dec 31, 2024 | 7,645 | 6 | |
| 2024Q3 | Sep 30, 2024 | 4,873 | 5 |
2026Q3 Earnings Call
Opening remarks
Thomas Errico Founder and Independent Chairman Thank you, operator. Good afternoon, everyone, and thank you for joining electroCore's Third Quarter 2026 Earnings Call. This quarter was about strengthening the foundation, leadership, commercial execution and regulatory clarity. The results strengthen my conviction and excitement about the company's current trajectory. This was a record quarter for electroCore, our highest net sales and our smallest operating loss in company history. Behind those results, management is building a commercial organization designed to grow profitably at a much larger scale. As with any transformation, the changes have been significant, and we believe the changes we have executed have established a foundation that positions electroCore for accelerated growth and an inflection point in positive adjusted EBITDA in 2027. For me, one of the most exciting developments is our progress opening new markets. On October 27, we filed our 510(k) premarket notification with the FDA seeking clearance for our Quell wearable neurostimulation device for the treatment of chemotherapy-induced peripheral neuropathy, or CIPN. This submission comes on the back of the breakthrough designation from the FDA in January 2022, which covers the reduction of moderate to severe symptoms of chemotherapy-induced peripheral neuropathy that have persisted for at least six months after chemotherapy ended. If cleared, Quell could offer a new nondrug option for patients experiencing CIPN, an important step for electroCore and those patients looking for symptom relief. Combined with continued progress in commercial execution and financial discipline, this new opportunity shows the path forward is stronger today than at any point in the last several years. Josh will take you through the quarter and where we are headed. Mike will walk you through the plans implemented for growth and measures we track in the field, and Josh will then return with the financials. Josh?
Joshua Lev Co-Chief Executive Officer, President and Chief Financial Officer Thank you, Tom. Good afternoon, everyone. This quarter, we delivered record net sales of $9.7 million, up approximately 12% from a year ago, and the lowest operating loss in our history, with adjusted EBITDA loss improving by nearly $1.4 million in the quarter, ahead of our expectations. Gross margin expanded to 88.5% and loss from operations narrowed to $1.6 million. GAAP net loss improved by $1.3 million, or $0.13 per share, from $3.1 million, or $0.33 per share, in the second quarter, and adjusted EBITDA loss improved to a company record $700,000. We grew revenue while spending less to do it. I will take you through the full financials later in the call. I want to be direct about where we are taking this company. We are not managing for short-term gains. We are building long-term revenue that is durable, repeatable and profitable.
Frequently Asked Questions About ECOR
When is Electrocore LLC's next earnings date?
Electrocore LLC's next earnings report is expected for Mar 17, 2027.
Did ECOR beat earnings estimates last quarter?
Yes. Electrocore LLC reported EPS of -$0.13 for the quarter ended Sep 30, 2026, above the -$0.26 estimate, a 50.00% surprise.
What EPS do analysts expect from ECOR next quarter?
The consensus EPS estimate for Electrocore LLC for the quarter ending Dec 31, 2026 is -$0.21 from 7 analysts, with estimates from -$0.25 to -$0.14.
How often does ECOR beat earnings estimates?
Electrocore LLC beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of +1.93%.
ECOR pages: Overview, Earnings, Forecast, Financials, Competitors, Government Contracts